Natrijev klorid Fresenius Kabi 9 mg/ml vehikel za parenteralno uporabo Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev klorid fresenius kabi 9 mg/ml vehikel za parenteralno uporabo

fresenius kabi espana s.a. - natrijev klorid - vehikel za parenteralno uporabo - natrijev klorid 9 mg / 1 ml - raztopine in pripravki za redčenje, vključno s tekočinami za izpiranje

Natrijev metamizolat Kalceks 500 mg/ml raztopina za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev metamizolat kalceks 500 mg/ml raztopina za injiciranje

as kalceks - natrijev metamizolat monohidrat - raztopina za injiciranje - natrijev metamizolat monohidrat 500 mg / 1 ampula - natrijev metamizolat

Natrijev metamizolat Kalceks 500 mg/ml raztopina za injiciranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev metamizolat kalceks 500 mg/ml raztopina za injiciranje

as kalceks - natrijev metamizolat monohidrat - raztopina za injiciranje - natrijev metamizolat monohidrat 500 mg / 1 ampula - natrijev metamizolat

Natrijev oksibat Accord 500 mg/ml peroralna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev oksibat accord 500 mg/ml peroralna raztopina

natrijev oksibat - peroralna raztopina - natrijev oksibat 500 mg / 1 ml - natrijev oksibat

Natrijev oksibat Kalceks 500 mg/ml peroralna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

natrijev oksibat kalceks 500 mg/ml peroralna raztopina

natrijev oksibat - peroralna raztopina - natrijev oksibat 500 mg / 1 ml - natrijev oksibat

Olicef 2 g prašek za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

olicef 2 g prašek za raztopino za infundiranje

krka, d.d., novo mesto - ceftriakson - prašek za raztopino za infundiranje - ceftriakson 2 g / 1 viala - ceftriakson

Pemetrexed Pfizer (previously Pemetrexed Hospira) Evropska unija - slovenščina - EMA (European Medicines Agency)

pemetrexed pfizer (previously pemetrexed hospira)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Kalijev klorid/natrijev klorid Kabi 3 mg/9 mg v 1 ml raztopina za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kalijev klorid/natrijev klorid kabi 3 mg/9 mg v 1 ml raztopina za infundiranje

fresenius kabi deutschland gmbh - kalijev klorid, natrijev klorid - raztopina za infundiranje - kalijev klorid 3 mg / 1 ml; natrijev klorid 9 mg / 1 ml - elektroliti

Edistride Evropska unija - slovenščina - EMA (European Medicines Agency)

edistride

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Forxiga Evropska unija - slovenščina - EMA (European Medicines Agency)

forxiga

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.